Neu-AZ1

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameNeu-AZ1
Drug Alias NameNeu-AZ2
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionCD44 antigen modulators
TargetsCD44 antigen
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNeurim Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNeurim Pharmaceuticals Ltd
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A